Reduced contraceptive efficacy; risk of unintended pregnancy
Advise use of alternative or additional contraception during antibiotic course
Source: KDT 7e · p948
Estrogen · Oral Contraceptive
Ethinylestradiol is a synthetic estrogen with a 17α-ethinyl substitution that protects against first-pass hepatic metabolism, making it 20-fold more potent orally than natural estradiol. It binds to estrogen receptors ERα and ERβ, acting as a nuclear transcription factor that modulates gene expression in reproductive tissues, bone, liver, and the cardiovascular system. At contraceptive doses, it suppresses FSH secretion via hypothalamic-pituitary negative feedback, inhibiting follicular development and ovulation.
Manufacturer advises avoid unless
Reduced contraceptive efficacy; risk of unintended pregnancy
Advise use of alternative or additional contraception during antibiotic course
Source: KDT 7e · p948
Reduced contraceptive efficacy; risk of unintended pregnancy
Advise use of alternative or additional contraception during antibiotic course
Source: KDT 7e · p948
Contraceptive failure
Advise alternative or higher-dose contraception
Source: KDT 7e · p949
Contraceptive failure
Advise alternative contraception
Source: KDT 7e · p948
Contraceptive failure
Advise alternative contraception
Source: KDT 7e · p949
Contraceptive failure
Advise alternative contraception
Source: KDT 7e · p949
Contraceptive failure
Advise alternative or higher-dose contraception
Source: KDT 7e · p949
Contraceptive failure
Advise alternative or higher-dose contraception
Source: KDT 7e · p949
Contraceptive failure
Advise alternative or higher-dose contraception
Source: KDT 7e · p949
Contraceptive failure
Advise alternative contraception
Source: KDT 7e · p948
Contraceptive failure
Advise alternative contraception
Source: KDT 7e · p949
Decreased effectiveness of oral contraception, leading to contraceptive failure and unwanted pregnancy.
Patients should use alternative or additional contraceptive methods while on rifampin and for a period after discontinuation.
Source: KDT 7e · p36
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: KD Tripathi 7e, BNF·Verified: 2026-05-13 · House clinical team